Global Conjugate Vaccines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Conjugate Vaccines market size was valued at USD 10280 million in 2023 and is forecast to a readjusted size of USD 13090 million by 2030 with a CAGR of 3.5% during review period.
Vaccines are used to prevent diseases by invoking an immune response to an antigen, the foreign part of a bacteria or virus that the immune system recognizes. Conjugate vaccines combine a weak antigen with a strong antigen as a carrier so that the immune system has a stronger response to the weak antigen.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Conjugate Vaccines industry chain, the market status of Children (Monovalent Conjugate Vaccines, Multivalent Conjugate Vaccines), Adults (Monovalent Conjugate Vaccines, Multivalent Conjugate Vaccines), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Conjugate Vaccines.
Regionally, the report analyzes the Conjugate Vaccines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Conjugate Vaccines market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Conjugate Vaccines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Conjugate Vaccines industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Units), revenue generated, and market share of different by Type (e.g., Monovalent Conjugate Vaccines, Multivalent Conjugate Vaccines).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Conjugate Vaccines market.
Regional Analysis: The report involves examining the Conjugate Vaccines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Conjugate Vaccines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Conjugate Vaccines:
Company Analysis: Report covers individual Conjugate Vaccines manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Conjugate Vaccines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Children, Adults).
Technology Analysis: Report covers specific technologies relevant to Conjugate Vaccines. It assesses the current state, advancements, and potential future developments in Conjugate Vaccines areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Conjugate Vaccines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Conjugate Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Conjugate Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Conjugate Vaccines, with price, sales, revenue and global market share of Conjugate Vaccines from 2019 to 2024.
Chapter 3, the Conjugate Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Conjugate Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Conjugate Vaccines market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Conjugate Vaccines.
Chapter 14 and 15, to describe Conjugate Vaccines sales channel, distributors, customers, research findings and conclusion.
Vaccines are used to prevent diseases by invoking an immune response to an antigen, the foreign part of a bacteria or virus that the immune system recognizes. Conjugate vaccines combine a weak antigen with a strong antigen as a carrier so that the immune system has a stronger response to the weak antigen.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Conjugate Vaccines industry chain, the market status of Children (Monovalent Conjugate Vaccines, Multivalent Conjugate Vaccines), Adults (Monovalent Conjugate Vaccines, Multivalent Conjugate Vaccines), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Conjugate Vaccines.
Regionally, the report analyzes the Conjugate Vaccines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Conjugate Vaccines market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Conjugate Vaccines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Conjugate Vaccines industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (Units), revenue generated, and market share of different by Type (e.g., Monovalent Conjugate Vaccines, Multivalent Conjugate Vaccines).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Conjugate Vaccines market.
Regional Analysis: The report involves examining the Conjugate Vaccines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Conjugate Vaccines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Conjugate Vaccines:
Company Analysis: Report covers individual Conjugate Vaccines manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Conjugate Vaccines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Children, Adults).
Technology Analysis: Report covers specific technologies relevant to Conjugate Vaccines. It assesses the current state, advancements, and potential future developments in Conjugate Vaccines areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Conjugate Vaccines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Conjugate Vaccines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Monovalent Conjugate Vaccines
- Multivalent Conjugate Vaccines
- Children
- Adults
- Novartis
- Neuron Biotech
- Serum Institute of India
- Pfizer
- Sanofi Pasteur
- Bharat Biotech
- Biological
- GlaxoSmithKline
- Merck
- CSL
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Conjugate Vaccines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Conjugate Vaccines, with price, sales, revenue and global market share of Conjugate Vaccines from 2019 to 2024.
Chapter 3, the Conjugate Vaccines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Conjugate Vaccines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Conjugate Vaccines market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Conjugate Vaccines.
Chapter 14 and 15, to describe Conjugate Vaccines sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Conjugate Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Conjugate Vaccines Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Monovalent Conjugate Vaccines
1.3.3 Multivalent Conjugate Vaccines
1.4 Market Analysis by Application
1.4.1 Overview: Global Conjugate Vaccines Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Children
1.4.3 Adults
1.5 Global Conjugate Vaccines Market Size & Forecast
1.5.1 Global Conjugate Vaccines Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Conjugate Vaccines Sales Quantity (2019-2030)
1.5.3 Global Conjugate Vaccines Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Conjugate Vaccines Product and Services
2.1.4 Novartis Conjugate Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Novartis Recent Developments/Updates
2.2 Neuron Biotech
2.2.1 Neuron Biotech Details
2.2.2 Neuron Biotech Major Business
2.2.3 Neuron Biotech Conjugate Vaccines Product and Services
2.2.4 Neuron Biotech Conjugate Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Neuron Biotech Recent Developments/Updates
2.3 Serum Institute of India
2.3.1 Serum Institute of India Details
2.3.2 Serum Institute of India Major Business
2.3.3 Serum Institute of India Conjugate Vaccines Product and Services
2.3.4 Serum Institute of India Conjugate Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Serum Institute of India Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Conjugate Vaccines Product and Services
2.4.4 Pfizer Conjugate Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Pfizer Recent Developments/Updates
2.5 Sanofi Pasteur
2.5.1 Sanofi Pasteur Details
2.5.2 Sanofi Pasteur Major Business
2.5.3 Sanofi Pasteur Conjugate Vaccines Product and Services
2.5.4 Sanofi Pasteur Conjugate Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Sanofi Pasteur Recent Developments/Updates
2.6 Bharat Biotech
2.6.1 Bharat Biotech Details
2.6.2 Bharat Biotech Major Business
2.6.3 Bharat Biotech Conjugate Vaccines Product and Services
2.6.4 Bharat Biotech Conjugate Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Bharat Biotech Recent Developments/Updates
2.7 Biological
2.7.1 Biological Details
2.7.2 Biological Major Business
2.7.3 Biological Conjugate Vaccines Product and Services
2.7.4 Biological Conjugate Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Biological Recent Developments/Updates
2.8 GlaxoSmithKline
2.8.1 GlaxoSmithKline Details
2.8.2 GlaxoSmithKline Major Business
2.8.3 GlaxoSmithKline Conjugate Vaccines Product and Services
2.8.4 GlaxoSmithKline Conjugate Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 GlaxoSmithKline Recent Developments/Updates
2.9 Merck
2.9.1 Merck Details
2.9.2 Merck Major Business
2.9.3 Merck Conjugate Vaccines Product and Services
2.9.4 Merck Conjugate Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Merck Recent Developments/Updates
2.10 CSL
2.10.1 CSL Details
2.10.2 CSL Major Business
2.10.3 CSL Conjugate Vaccines Product and Services
2.10.4 CSL Conjugate Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 CSL Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: CONJUGATE VACCINES BY MANUFACTURER
3.1 Global Conjugate Vaccines Sales Quantity by Manufacturer (2019-2024)
3.2 Global Conjugate Vaccines Revenue by Manufacturer (2019-2024)
3.3 Global Conjugate Vaccines Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Conjugate Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Conjugate Vaccines Manufacturer Market Share in 2023
3.4.2 Top 6 Conjugate Vaccines Manufacturer Market Share in 2023
3.5 Conjugate Vaccines Market: Overall Company Footprint Analysis
3.5.1 Conjugate Vaccines Market: Region Footprint
3.5.2 Conjugate Vaccines Market: Company Product Type Footprint
3.5.3 Conjugate Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Conjugate Vaccines Market Size by Region
4.1.1 Global Conjugate Vaccines Sales Quantity by Region (2019-2030)
4.1.2 Global Conjugate Vaccines Consumption Value by Region (2019-2030)
4.1.3 Global Conjugate Vaccines Average Price by Region (2019-2030)
4.2 North America Conjugate Vaccines Consumption Value (2019-2030)
4.3 Europe Conjugate Vaccines Consumption Value (2019-2030)
4.4 Asia-Pacific Conjugate Vaccines Consumption Value (2019-2030)
4.5 South America Conjugate Vaccines Consumption Value (2019-2030)
4.6 Middle East and Africa Conjugate Vaccines Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Conjugate Vaccines Sales Quantity by Type (2019-2030)
5.2 Global Conjugate Vaccines Consumption Value by Type (2019-2030)
5.3 Global Conjugate Vaccines Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Conjugate Vaccines Sales Quantity by Application (2019-2030)
6.2 Global Conjugate Vaccines Consumption Value by Application (2019-2030)
6.3 Global Conjugate Vaccines Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Conjugate Vaccines Sales Quantity by Type (2019-2030)
7.2 North America Conjugate Vaccines Sales Quantity by Application (2019-2030)
7.3 North America Conjugate Vaccines Market Size by Country
7.3.1 North America Conjugate Vaccines Sales Quantity by Country (2019-2030)
7.3.2 North America Conjugate Vaccines Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Conjugate Vaccines Sales Quantity by Type (2019-2030)
8.2 Europe Conjugate Vaccines Sales Quantity by Application (2019-2030)
8.3 Europe Conjugate Vaccines Market Size by Country
8.3.1 Europe Conjugate Vaccines Sales Quantity by Country (2019-2030)
8.3.2 Europe Conjugate Vaccines Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Conjugate Vaccines Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Conjugate Vaccines Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Conjugate Vaccines Market Size by Region
9.3.1 Asia-Pacific Conjugate Vaccines Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Conjugate Vaccines Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Conjugate Vaccines Sales Quantity by Type (2019-2030)
10.2 South America Conjugate Vaccines Sales Quantity by Application (2019-2030)
10.3 South America Conjugate Vaccines Market Size by Country
10.3.1 South America Conjugate Vaccines Sales Quantity by Country (2019-2030)
10.3.2 South America Conjugate Vaccines Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Conjugate Vaccines Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Conjugate Vaccines Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Conjugate Vaccines Market Size by Country
11.3.1 Middle East & Africa Conjugate Vaccines Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Conjugate Vaccines Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Conjugate Vaccines Market Drivers
12.2 Conjugate Vaccines Market Restraints
12.3 Conjugate Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Conjugate Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Conjugate Vaccines
13.3 Conjugate Vaccines Production Process
13.4 Conjugate Vaccines Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Conjugate Vaccines Typical Distributors
14.3 Conjugate Vaccines Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Conjugate Vaccines
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Conjugate Vaccines Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Monovalent Conjugate Vaccines
1.3.3 Multivalent Conjugate Vaccines
1.4 Market Analysis by Application
1.4.1 Overview: Global Conjugate Vaccines Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Children
1.4.3 Adults
1.5 Global Conjugate Vaccines Market Size & Forecast
1.5.1 Global Conjugate Vaccines Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Conjugate Vaccines Sales Quantity (2019-2030)
1.5.3 Global Conjugate Vaccines Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis Conjugate Vaccines Product and Services
2.1.4 Novartis Conjugate Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Novartis Recent Developments/Updates
2.2 Neuron Biotech
2.2.1 Neuron Biotech Details
2.2.2 Neuron Biotech Major Business
2.2.3 Neuron Biotech Conjugate Vaccines Product and Services
2.2.4 Neuron Biotech Conjugate Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Neuron Biotech Recent Developments/Updates
2.3 Serum Institute of India
2.3.1 Serum Institute of India Details
2.3.2 Serum Institute of India Major Business
2.3.3 Serum Institute of India Conjugate Vaccines Product and Services
2.3.4 Serum Institute of India Conjugate Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Serum Institute of India Recent Developments/Updates
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Conjugate Vaccines Product and Services
2.4.4 Pfizer Conjugate Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Pfizer Recent Developments/Updates
2.5 Sanofi Pasteur
2.5.1 Sanofi Pasteur Details
2.5.2 Sanofi Pasteur Major Business
2.5.3 Sanofi Pasteur Conjugate Vaccines Product and Services
2.5.4 Sanofi Pasteur Conjugate Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Sanofi Pasteur Recent Developments/Updates
2.6 Bharat Biotech
2.6.1 Bharat Biotech Details
2.6.2 Bharat Biotech Major Business
2.6.3 Bharat Biotech Conjugate Vaccines Product and Services
2.6.4 Bharat Biotech Conjugate Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Bharat Biotech Recent Developments/Updates
2.7 Biological
2.7.1 Biological Details
2.7.2 Biological Major Business
2.7.3 Biological Conjugate Vaccines Product and Services
2.7.4 Biological Conjugate Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Biological Recent Developments/Updates
2.8 GlaxoSmithKline
2.8.1 GlaxoSmithKline Details
2.8.2 GlaxoSmithKline Major Business
2.8.3 GlaxoSmithKline Conjugate Vaccines Product and Services
2.8.4 GlaxoSmithKline Conjugate Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 GlaxoSmithKline Recent Developments/Updates
2.9 Merck
2.9.1 Merck Details
2.9.2 Merck Major Business
2.9.3 Merck Conjugate Vaccines Product and Services
2.9.4 Merck Conjugate Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Merck Recent Developments/Updates
2.10 CSL
2.10.1 CSL Details
2.10.2 CSL Major Business
2.10.3 CSL Conjugate Vaccines Product and Services
2.10.4 CSL Conjugate Vaccines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 CSL Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: CONJUGATE VACCINES BY MANUFACTURER
3.1 Global Conjugate Vaccines Sales Quantity by Manufacturer (2019-2024)
3.2 Global Conjugate Vaccines Revenue by Manufacturer (2019-2024)
3.3 Global Conjugate Vaccines Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Conjugate Vaccines by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Conjugate Vaccines Manufacturer Market Share in 2023
3.4.2 Top 6 Conjugate Vaccines Manufacturer Market Share in 2023
3.5 Conjugate Vaccines Market: Overall Company Footprint Analysis
3.5.1 Conjugate Vaccines Market: Region Footprint
3.5.2 Conjugate Vaccines Market: Company Product Type Footprint
3.5.3 Conjugate Vaccines Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Conjugate Vaccines Market Size by Region
4.1.1 Global Conjugate Vaccines Sales Quantity by Region (2019-2030)
4.1.2 Global Conjugate Vaccines Consumption Value by Region (2019-2030)
4.1.3 Global Conjugate Vaccines Average Price by Region (2019-2030)
4.2 North America Conjugate Vaccines Consumption Value (2019-2030)
4.3 Europe Conjugate Vaccines Consumption Value (2019-2030)
4.4 Asia-Pacific Conjugate Vaccines Consumption Value (2019-2030)
4.5 South America Conjugate Vaccines Consumption Value (2019-2030)
4.6 Middle East and Africa Conjugate Vaccines Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Conjugate Vaccines Sales Quantity by Type (2019-2030)
5.2 Global Conjugate Vaccines Consumption Value by Type (2019-2030)
5.3 Global Conjugate Vaccines Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Conjugate Vaccines Sales Quantity by Application (2019-2030)
6.2 Global Conjugate Vaccines Consumption Value by Application (2019-2030)
6.3 Global Conjugate Vaccines Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Conjugate Vaccines Sales Quantity by Type (2019-2030)
7.2 North America Conjugate Vaccines Sales Quantity by Application (2019-2030)
7.3 North America Conjugate Vaccines Market Size by Country
7.3.1 North America Conjugate Vaccines Sales Quantity by Country (2019-2030)
7.3.2 North America Conjugate Vaccines Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Conjugate Vaccines Sales Quantity by Type (2019-2030)
8.2 Europe Conjugate Vaccines Sales Quantity by Application (2019-2030)
8.3 Europe Conjugate Vaccines Market Size by Country
8.3.1 Europe Conjugate Vaccines Sales Quantity by Country (2019-2030)
8.3.2 Europe Conjugate Vaccines Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Conjugate Vaccines Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Conjugate Vaccines Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Conjugate Vaccines Market Size by Region
9.3.1 Asia-Pacific Conjugate Vaccines Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Conjugate Vaccines Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Conjugate Vaccines Sales Quantity by Type (2019-2030)
10.2 South America Conjugate Vaccines Sales Quantity by Application (2019-2030)
10.3 South America Conjugate Vaccines Market Size by Country
10.3.1 South America Conjugate Vaccines Sales Quantity by Country (2019-2030)
10.3.2 South America Conjugate Vaccines Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Conjugate Vaccines Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Conjugate Vaccines Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Conjugate Vaccines Market Size by Country
11.3.1 Middle East & Africa Conjugate Vaccines Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Conjugate Vaccines Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Conjugate Vaccines Market Drivers
12.2 Conjugate Vaccines Market Restraints
12.3 Conjugate Vaccines Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Conjugate Vaccines and Key Manufacturers
13.2 Manufacturing Costs Percentage of Conjugate Vaccines
13.3 Conjugate Vaccines Production Process
13.4 Conjugate Vaccines Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Conjugate Vaccines Typical Distributors
14.3 Conjugate Vaccines Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Conjugate Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Conjugate Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Conjugate Vaccines Product and Services
Table 6. Novartis Conjugate Vaccines Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Novartis Recent Developments/Updates
Table 8. Neuron Biotech Basic Information, Manufacturing Base and Competitors
Table 9. Neuron Biotech Major Business
Table 10. Neuron Biotech Conjugate Vaccines Product and Services
Table 11. Neuron Biotech Conjugate Vaccines Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Neuron Biotech Recent Developments/Updates
Table 13. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 14. Serum Institute of India Major Business
Table 15. Serum Institute of India Conjugate Vaccines Product and Services
Table 16. Serum Institute of India Conjugate Vaccines Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Serum Institute of India Recent Developments/Updates
Table 18. Pfizer Basic Information, Manufacturing Base and Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer Conjugate Vaccines Product and Services
Table 21. Pfizer Conjugate Vaccines Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Pfizer Recent Developments/Updates
Table 23. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi Pasteur Major Business
Table 25. Sanofi Pasteur Conjugate Vaccines Product and Services
Table 26. Sanofi Pasteur Conjugate Vaccines Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Sanofi Pasteur Recent Developments/Updates
Table 28. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 29. Bharat Biotech Major Business
Table 30. Bharat Biotech Conjugate Vaccines Product and Services
Table 31. Bharat Biotech Conjugate Vaccines Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Bharat Biotech Recent Developments/Updates
Table 33. Biological Basic Information, Manufacturing Base and Competitors
Table 34. Biological Major Business
Table 35. Biological Conjugate Vaccines Product and Services
Table 36. Biological Conjugate Vaccines Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Biological Recent Developments/Updates
Table 38. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 39. GlaxoSmithKline Major Business
Table 40. GlaxoSmithKline Conjugate Vaccines Product and Services
Table 41. GlaxoSmithKline Conjugate Vaccines Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. GlaxoSmithKline Recent Developments/Updates
Table 43. Merck Basic Information, Manufacturing Base and Competitors
Table 44. Merck Major Business
Table 45. Merck Conjugate Vaccines Product and Services
Table 46. Merck Conjugate Vaccines Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Merck Recent Developments/Updates
Table 48. CSL Basic Information, Manufacturing Base and Competitors
Table 49. CSL Major Business
Table 50. CSL Conjugate Vaccines Product and Services
Table 51. CSL Conjugate Vaccines Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. CSL Recent Developments/Updates
Table 53. Global Conjugate Vaccines Sales Quantity by Manufacturer (2019-2024) & (Units)
Table 54. Global Conjugate Vaccines Revenue by Manufacturer (2019-2024) & (USD Million)
Table 55. Global Conjugate Vaccines Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 56. Market Position of Manufacturers in Conjugate Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 57. Head Office and Conjugate Vaccines Production Site of Key Manufacturer
Table 58. Conjugate Vaccines Market: Company Product Type Footprint
Table 59. Conjugate Vaccines Market: Company Product Application Footprint
Table 60. Conjugate Vaccines New Market Entrants and Barriers to Market Entry
Table 61. Conjugate Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Conjugate Vaccines Sales Quantity by Region (2019-2024) & (Units)
Table 63. Global Conjugate Vaccines Sales Quantity by Region (2025-2030) & (Units)
Table 64. Global Conjugate Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 65. Global Conjugate Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 66. Global Conjugate Vaccines Average Price by Region (2019-2024) & (USD/Unit)
Table 67. Global Conjugate Vaccines Average Price by Region (2025-2030) & (USD/Unit)
Table 68. Global Conjugate Vaccines Sales Quantity by Type (2019-2024) & (Units)
Table 69. Global Conjugate Vaccines Sales Quantity by Type (2025-2030) & (Units)
Table 70. Global Conjugate Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Global Conjugate Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Global Conjugate Vaccines Average Price by Type (2019-2024) & (USD/Unit)
Table 73. Global Conjugate Vaccines Average Price by Type (2025-2030) & (USD/Unit)
Table 74. Global Conjugate Vaccines Sales Quantity by Application (2019-2024) & (Units)
Table 75. Global Conjugate Vaccines Sales Quantity by Application (2025-2030) & (Units)
Table 76. Global Conjugate Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 77. Global Conjugate Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 78. Global Conjugate Vaccines Average Price by Application (2019-2024) & (USD/Unit)
Table 79. Global Conjugate Vaccines Average Price by Application (2025-2030) & (USD/Unit)
Table 80. North America Conjugate Vaccines Sales Quantity by Type (2019-2024) & (Units)
Table 81. North America Conjugate Vaccines Sales Quantity by Type (2025-2030) & (Units)
Table 82. North America Conjugate Vaccines Sales Quantity by Application (2019-2024) & (Units)
Table 83. North America Conjugate Vaccines Sales Quantity by Application (2025-2030) & (Units)
Table 84. North America Conjugate Vaccines Sales Quantity by Country (2019-2024) & (Units)
Table 85. North America Conjugate Vaccines Sales Quantity by Country (2025-2030) & (Units)
Table 86. North America Conjugate Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 87. North America Conjugate Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Europe Conjugate Vaccines Sales Quantity by Type (2019-2024) & (Units)
Table 89. Europe Conjugate Vaccines Sales Quantity by Type (2025-2030) & (Units)
Table 90. Europe Conjugate Vaccines Sales Quantity by Application (2019-2024) & (Units)
Table 91. Europe Conjugate Vaccines Sales Quantity by Application (2025-2030) & (Units)
Table 92. Europe Conjugate Vaccines Sales Quantity by Country (2019-2024) & (Units)
Table 93. Europe Conjugate Vaccines Sales Quantity by Country (2025-2030) & (Units)
Table 94. Europe Conjugate Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Conjugate Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Conjugate Vaccines Sales Quantity by Type (2019-2024) & (Units)
Table 97. Asia-Pacific Conjugate Vaccines Sales Quantity by Type (2025-2030) & (Units)
Table 98. Asia-Pacific Conjugate Vaccines Sales Quantity by Application (2019-2024) & (Units)
Table 99. Asia-Pacific Conjugate Vaccines Sales Quantity by Application (2025-2030) & (Units)
Table 100. Asia-Pacific Conjugate Vaccines Sales Quantity by Region (2019-2024) & (Units)
Table 101. Asia-Pacific Conjugate Vaccines Sales Quantity by Region (2025-2030) & (Units)
Table 102. Asia-Pacific Conjugate Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 103. Asia-Pacific Conjugate Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 104. South America Conjugate Vaccines Sales Quantity by Type (2019-2024) & (Units)
Table 105. South America Conjugate Vaccines Sales Quantity by Type (2025-2030) & (Units)
Table 106. South America Conjugate Vaccines Sales Quantity by Application (2019-2024) & (Units)
Table 107. South America Conjugate Vaccines Sales Quantity by Application (2025-2030) & (Units)
Table 108. South America Conjugate Vaccines Sales Quantity by Country (2019-2024) & (Units)
Table 109. South America Conjugate Vaccines Sales Quantity by Country (2025-2030) & (Units)
Table 110. South America Conjugate Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 111. South America Conjugate Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 112. Middle East & Africa Conjugate Vaccines Sales Quantity by Type (2019-2024) & (Units)
Table 113. Middle East & Africa Conjugate Vaccines Sales Quantity by Type (2025-2030) & (Units)
Table 114. Middle East & Africa Conjugate Vaccines Sales Quantity by Application (2019-2024) & (Units)
Table 115. Middle East & Africa Conjugate Vaccines Sales Quantity by Application (2025-2030) & (Units)
Table 116. Middle East & Africa Conjugate Vaccines Sales Quantity by Region (2019-2024) & (Units)
Table 117. Middle East & Africa Conjugate Vaccines Sales Quantity by Region (2025-2030) & (Units)
Table 118. Middle East & Africa Conjugate Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 119. Middle East & Africa Conjugate Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 120. Conjugate Vaccines Raw Material
Table 121. Key Manufacturers of Conjugate Vaccines Raw Materials
Table 122. Conjugate Vaccines Typical Distributors
Table 123. Conjugate Vaccines Typical Customers
Table 1. Global Conjugate Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Conjugate Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Novartis Basic Information, Manufacturing Base and Competitors
Table 4. Novartis Major Business
Table 5. Novartis Conjugate Vaccines Product and Services
Table 6. Novartis Conjugate Vaccines Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Novartis Recent Developments/Updates
Table 8. Neuron Biotech Basic Information, Manufacturing Base and Competitors
Table 9. Neuron Biotech Major Business
Table 10. Neuron Biotech Conjugate Vaccines Product and Services
Table 11. Neuron Biotech Conjugate Vaccines Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Neuron Biotech Recent Developments/Updates
Table 13. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 14. Serum Institute of India Major Business
Table 15. Serum Institute of India Conjugate Vaccines Product and Services
Table 16. Serum Institute of India Conjugate Vaccines Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Serum Institute of India Recent Developments/Updates
Table 18. Pfizer Basic Information, Manufacturing Base and Competitors
Table 19. Pfizer Major Business
Table 20. Pfizer Conjugate Vaccines Product and Services
Table 21. Pfizer Conjugate Vaccines Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Pfizer Recent Developments/Updates
Table 23. Sanofi Pasteur Basic Information, Manufacturing Base and Competitors
Table 24. Sanofi Pasteur Major Business
Table 25. Sanofi Pasteur Conjugate Vaccines Product and Services
Table 26. Sanofi Pasteur Conjugate Vaccines Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Sanofi Pasteur Recent Developments/Updates
Table 28. Bharat Biotech Basic Information, Manufacturing Base and Competitors
Table 29. Bharat Biotech Major Business
Table 30. Bharat Biotech Conjugate Vaccines Product and Services
Table 31. Bharat Biotech Conjugate Vaccines Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Bharat Biotech Recent Developments/Updates
Table 33. Biological Basic Information, Manufacturing Base and Competitors
Table 34. Biological Major Business
Table 35. Biological Conjugate Vaccines Product and Services
Table 36. Biological Conjugate Vaccines Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Biological Recent Developments/Updates
Table 38. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 39. GlaxoSmithKline Major Business
Table 40. GlaxoSmithKline Conjugate Vaccines Product and Services
Table 41. GlaxoSmithKline Conjugate Vaccines Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. GlaxoSmithKline Recent Developments/Updates
Table 43. Merck Basic Information, Manufacturing Base and Competitors
Table 44. Merck Major Business
Table 45. Merck Conjugate Vaccines Product and Services
Table 46. Merck Conjugate Vaccines Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Merck Recent Developments/Updates
Table 48. CSL Basic Information, Manufacturing Base and Competitors
Table 49. CSL Major Business
Table 50. CSL Conjugate Vaccines Product and Services
Table 51. CSL Conjugate Vaccines Sales Quantity (Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. CSL Recent Developments/Updates
Table 53. Global Conjugate Vaccines Sales Quantity by Manufacturer (2019-2024) & (Units)
Table 54. Global Conjugate Vaccines Revenue by Manufacturer (2019-2024) & (USD Million)
Table 55. Global Conjugate Vaccines Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 56. Market Position of Manufacturers in Conjugate Vaccines, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 57. Head Office and Conjugate Vaccines Production Site of Key Manufacturer
Table 58. Conjugate Vaccines Market: Company Product Type Footprint
Table 59. Conjugate Vaccines Market: Company Product Application Footprint
Table 60. Conjugate Vaccines New Market Entrants and Barriers to Market Entry
Table 61. Conjugate Vaccines Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Conjugate Vaccines Sales Quantity by Region (2019-2024) & (Units)
Table 63. Global Conjugate Vaccines Sales Quantity by Region (2025-2030) & (Units)
Table 64. Global Conjugate Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 65. Global Conjugate Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 66. Global Conjugate Vaccines Average Price by Region (2019-2024) & (USD/Unit)
Table 67. Global Conjugate Vaccines Average Price by Region (2025-2030) & (USD/Unit)
Table 68. Global Conjugate Vaccines Sales Quantity by Type (2019-2024) & (Units)
Table 69. Global Conjugate Vaccines Sales Quantity by Type (2025-2030) & (Units)
Table 70. Global Conjugate Vaccines Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Global Conjugate Vaccines Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Global Conjugate Vaccines Average Price by Type (2019-2024) & (USD/Unit)
Table 73. Global Conjugate Vaccines Average Price by Type (2025-2030) & (USD/Unit)
Table 74. Global Conjugate Vaccines Sales Quantity by Application (2019-2024) & (Units)
Table 75. Global Conjugate Vaccines Sales Quantity by Application (2025-2030) & (Units)
Table 76. Global Conjugate Vaccines Consumption Value by Application (2019-2024) & (USD Million)
Table 77. Global Conjugate Vaccines Consumption Value by Application (2025-2030) & (USD Million)
Table 78. Global Conjugate Vaccines Average Price by Application (2019-2024) & (USD/Unit)
Table 79. Global Conjugate Vaccines Average Price by Application (2025-2030) & (USD/Unit)
Table 80. North America Conjugate Vaccines Sales Quantity by Type (2019-2024) & (Units)
Table 81. North America Conjugate Vaccines Sales Quantity by Type (2025-2030) & (Units)
Table 82. North America Conjugate Vaccines Sales Quantity by Application (2019-2024) & (Units)
Table 83. North America Conjugate Vaccines Sales Quantity by Application (2025-2030) & (Units)
Table 84. North America Conjugate Vaccines Sales Quantity by Country (2019-2024) & (Units)
Table 85. North America Conjugate Vaccines Sales Quantity by Country (2025-2030) & (Units)
Table 86. North America Conjugate Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 87. North America Conjugate Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Europe Conjugate Vaccines Sales Quantity by Type (2019-2024) & (Units)
Table 89. Europe Conjugate Vaccines Sales Quantity by Type (2025-2030) & (Units)
Table 90. Europe Conjugate Vaccines Sales Quantity by Application (2019-2024) & (Units)
Table 91. Europe Conjugate Vaccines Sales Quantity by Application (2025-2030) & (Units)
Table 92. Europe Conjugate Vaccines Sales Quantity by Country (2019-2024) & (Units)
Table 93. Europe Conjugate Vaccines Sales Quantity by Country (2025-2030) & (Units)
Table 94. Europe Conjugate Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Conjugate Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Conjugate Vaccines Sales Quantity by Type (2019-2024) & (Units)
Table 97. Asia-Pacific Conjugate Vaccines Sales Quantity by Type (2025-2030) & (Units)
Table 98. Asia-Pacific Conjugate Vaccines Sales Quantity by Application (2019-2024) & (Units)
Table 99. Asia-Pacific Conjugate Vaccines Sales Quantity by Application (2025-2030) & (Units)
Table 100. Asia-Pacific Conjugate Vaccines Sales Quantity by Region (2019-2024) & (Units)
Table 101. Asia-Pacific Conjugate Vaccines Sales Quantity by Region (2025-2030) & (Units)
Table 102. Asia-Pacific Conjugate Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 103. Asia-Pacific Conjugate Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 104. South America Conjugate Vaccines Sales Quantity by Type (2019-2024) & (Units)
Table 105. South America Conjugate Vaccines Sales Quantity by Type (2025-2030) & (Units)
Table 106. South America Conjugate Vaccines Sales Quantity by Application (2019-2024) & (Units)
Table 107. South America Conjugate Vaccines Sales Quantity by Application (2025-2030) & (Units)
Table 108. South America Conjugate Vaccines Sales Quantity by Country (2019-2024) & (Units)
Table 109. South America Conjugate Vaccines Sales Quantity by Country (2025-2030) & (Units)
Table 110. South America Conjugate Vaccines Consumption Value by Country (2019-2024) & (USD Million)
Table 111. South America Conjugate Vaccines Consumption Value by Country (2025-2030) & (USD Million)
Table 112. Middle East & Africa Conjugate Vaccines Sales Quantity by Type (2019-2024) & (Units)
Table 113. Middle East & Africa Conjugate Vaccines Sales Quantity by Type (2025-2030) & (Units)
Table 114. Middle East & Africa Conjugate Vaccines Sales Quantity by Application (2019-2024) & (Units)
Table 115. Middle East & Africa Conjugate Vaccines Sales Quantity by Application (2025-2030) & (Units)
Table 116. Middle East & Africa Conjugate Vaccines Sales Quantity by Region (2019-2024) & (Units)
Table 117. Middle East & Africa Conjugate Vaccines Sales Quantity by Region (2025-2030) & (Units)
Table 118. Middle East & Africa Conjugate Vaccines Consumption Value by Region (2019-2024) & (USD Million)
Table 119. Middle East & Africa Conjugate Vaccines Consumption Value by Region (2025-2030) & (USD Million)
Table 120. Conjugate Vaccines Raw Material
Table 121. Key Manufacturers of Conjugate Vaccines Raw Materials
Table 122. Conjugate Vaccines Typical Distributors
Table 123. Conjugate Vaccines Typical Customers
LIST OF FIGURES
Figure 1. Conjugate Vaccines Picture
Figure 2. Global Conjugate Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Conjugate Vaccines Consumption Value Market Share by Type in 2023
Figure 4. Monovalent Conjugate Vaccines Examples
Figure 5. Multivalent Conjugate Vaccines Examples
Figure 6. Global Conjugate Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Conjugate Vaccines Consumption Value Market Share by Application in 2023
Figure 8. Children Examples
Figure 9. Adults Examples
Figure 10. Global Conjugate Vaccines Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Conjugate Vaccines Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Conjugate Vaccines Sales Quantity (2019-2030) & (Units)
Figure 13. Global Conjugate Vaccines Average Price (2019-2030) & (USD/Unit)
Figure 14. Global Conjugate Vaccines Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Conjugate Vaccines Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Conjugate Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 Conjugate Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 Conjugate Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global Conjugate Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Conjugate Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Conjugate Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Conjugate Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Conjugate Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Conjugate Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Conjugate Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Conjugate Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Conjugate Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Conjugate Vaccines Average Price by Type (2019-2030) & (USD/Unit)
Figure 29. Global Conjugate Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Conjugate Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 31. Global Conjugate Vaccines Average Price by Application (2019-2030) & (USD/Unit)
Figure 32. North America Conjugate Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Conjugate Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Conjugate Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Conjugate Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe Conjugate Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Conjugate Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Conjugate Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Conjugate Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Conjugate Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Conjugate Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Conjugate Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Conjugate Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 52. China Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America Conjugate Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Conjugate Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Conjugate Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Conjugate Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Conjugate Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Conjugate Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Conjugate Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa Conjugate Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Conjugate Vaccines Market Drivers
Figure 73. Conjugate Vaccines Market Restraints
Figure 74. Conjugate Vaccines Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Conjugate Vaccines in 2023
Figure 77. Manufacturing Process Analysis of Conjugate Vaccines
Figure 78. Conjugate Vaccines Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. Conjugate Vaccines Picture
Figure 2. Global Conjugate Vaccines Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Conjugate Vaccines Consumption Value Market Share by Type in 2023
Figure 4. Monovalent Conjugate Vaccines Examples
Figure 5. Multivalent Conjugate Vaccines Examples
Figure 6. Global Conjugate Vaccines Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Conjugate Vaccines Consumption Value Market Share by Application in 2023
Figure 8. Children Examples
Figure 9. Adults Examples
Figure 10. Global Conjugate Vaccines Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Conjugate Vaccines Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Conjugate Vaccines Sales Quantity (2019-2030) & (Units)
Figure 13. Global Conjugate Vaccines Average Price (2019-2030) & (USD/Unit)
Figure 14. Global Conjugate Vaccines Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Conjugate Vaccines Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Conjugate Vaccines by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 Conjugate Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 Conjugate Vaccines Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global Conjugate Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Conjugate Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Conjugate Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Conjugate Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Conjugate Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Conjugate Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Conjugate Vaccines Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Conjugate Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Conjugate Vaccines Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Conjugate Vaccines Average Price by Type (2019-2030) & (USD/Unit)
Figure 29. Global Conjugate Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Conjugate Vaccines Consumption Value Market Share by Application (2019-2030)
Figure 31. Global Conjugate Vaccines Average Price by Application (2019-2030) & (USD/Unit)
Figure 32. North America Conjugate Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Conjugate Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Conjugate Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Conjugate Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe Conjugate Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Conjugate Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Conjugate Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Conjugate Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Conjugate Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Conjugate Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Conjugate Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Conjugate Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 52. China Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America Conjugate Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Conjugate Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Conjugate Vaccines Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Conjugate Vaccines Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Conjugate Vaccines Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Conjugate Vaccines Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Conjugate Vaccines Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa Conjugate Vaccines Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa Conjugate Vaccines Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Conjugate Vaccines Market Drivers
Figure 73. Conjugate Vaccines Market Restraints
Figure 74. Conjugate Vaccines Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Conjugate Vaccines in 2023
Figure 77. Manufacturing Process Analysis of Conjugate Vaccines
Figure 78. Conjugate Vaccines Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
